Senior Advisor and Co-Founder
Longview Leader Corp
Kurt Nielsen, Ph.D. is currently, Senior Advisor and Co-Founder of Longview Leader, a management consulting and advisory services firm in healthcare. Dr. Nielsen's previous leadership roles were President and CEO of Pharmaceutics International Inc. (Pii), a science-driven pharmaceutical contract development and manufacturing organization (CDMO) based in the US, President of Lupin Somerset (an Operating Division of Lupin, Inc) within Lupin Ltd. (BOM:500257) an innovation led transnational pharmaceutical company which is the 6th largest generics pharmaceutical company, VP of US Development, Portfolio and Launch Management at Sandoz Inc, part of the Novartis group (NYSE:NVS), Senior Vice President of R&D and Chief Technology Officer for Catalent Inc. (NYSE:CTLT), Executive Vice President of Pharmaceuticals for URL Pharma and Executive Director of Generic R&D for TEVA Pharmaceuticals (NYSE:TEVA).
Dr. Nielsen's 25 years of experience in generic, brand, biotech, and consumer health pharmaceutical companies includes a strong background in managing businesses, developing and launching new products for global markets, regulatory strategy, sales and marketing of products and technologies, complex international licensing transactions, as well as, M&A.
Dr. Nielsen has a BS in Chemistry from the University of Delaware and a Ph.D. in Chemistry from Villanova University.
Disclosure information not submitted.
Tuesday, October 18, 2022
3:00 PM – 4:00 PM ET